-
DiscoveryJul 14, 2021Helping clinical trial patients during a lockdownYan Zhao talks about how her team in China responded to an emerging public health crisis.
Discovery -
Access to HealthcareJul 21, 2021Cancer didn’t stop for COVID-19Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to Healthcare -
Access to HealthcareJul 30, 2021Streamlining systems to respond to COVID-19Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
DiscoveryJul 15, 2021Moving from speculation to science during a pandemicFlorencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Discovery -
DiscoveryJul 15, 2021It takes an R&D village to fight a pandemicGervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Discovery -
From Our LabsJul 20, 2021A visual tour of scientific strategies for combating coronavirusResearchers around the world are collaborating to provide solutions to immediate and future challenges.
From Our Labs -
People and CultureAug 10, 2021Going the extra mile to keep clinical trials on track during the COVID-19 pandemicA Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
People and Culture -
DiscoveryJul 14, 2021COVID-19: Answering your top questionsNovartis CEO Vas Narasimhan answers questions about COVID-19.
Discovery -
DiscoverySep 27, 2021Visualizing molecular gluesMolecular glues are a new type of medicine inspired by nature’s matchmakers.
Discovery -
Patient PerspectivesAug 6, 2021Caring for someone with heart failureCaring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
Patient Perspectives -
Jul 14, 2021The data42 program shows Novartis’ intent to go big on data and digitalNovartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
-
DiscoveryJul 15, 2021Meet Achim, leading the data42 programThe recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
Discovery